HLUBF:OTCMKTS
H Lundbeck A/S Class A
$7.94
0.00%
(0.00) 1D
Nov 9, 3:17:57 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUBF...
Mkt. cap
58.85B
Avg. vol.
113.00
Volume
0.00
52-wk high
$7.94
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
Mkt. cap
58.85B
Avg. vol.
113.00
Volume
0.00
52-wk high
$7.94
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
News stories
From web sources and news partners
MedWatch
·
1 hour ago
Danske Bank sees big upside for Lundbeck if late-stage trials succeed
Morningstar
·
4 hours ago
Strong Demand For Vyepti Drives Improved Near-Term Outlook For Lundbeck
GuruFocus
·
14 hours ago
H. Lundbeck AS (HLUBF) (Q3 2026) Earnings Call Highlights: Raised Guidance and Strong Vyepti Momentum
Investing.com
·
20 hours ago
Earnings call transcript: Lundbeck lifts 2026 outlook on strong Q3 growth
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5K
Founded1915
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitelundbeck.com